Position in NVS
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$2,695,584
+$260,138 QoQ
Shares Held
17,200
+7.9% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#369
of 1,603 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 74%
Shared 0%
None 26%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Aptus Capital Advisors, LLC holds $223,621,682 across 14 Drug Manufacturers - General names. NVS ranks #9 (1.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
53,662 | $64,363,817 | |
| 2 | JNJ |
Johnson & Johnson
|
201,691 | $51,223,462 | |
| 3 | ABBV |
AbbVie Inc.
|
142,030 | $35,740,429 | |
| 4 | MRK |
Merck & Co., Inc.
|
201,987 | $25,955,329 | |
| 5 | AMGN |
Amgen Inc
|
42,764 | $15,485,699 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
74,929 | $9,466,529 | |
| 7 | PFE |
Pfizer Inc
|
365,411 | $8,799,096 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
134,318 | $7,739,403 |
All Filings in NVS
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,695,584 | 17,200 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $2,435,446 | 15,944 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $2,197,096 | 15,936 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $1,960,789 | 15,290 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $1,955,037 | 16,156 | Shares | Sole | 2025-08-11 | |
| 2025-03-31 | $1,828,049 | 16,398 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $1,559,490 | 16,026 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $522,995 | 4,547 | Shares | Sole | 2024-11-05 | |
| 2024-06-30 | $491,419 | 4,616 | Shares | Sole | 2024-07-31 | |
| 2024-03-31 | $441,475 | 4,564 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $398,124 | 3,943 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $420,172 | 4,125 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $357,826 | 3,546 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $232,944 | 2,532 | Shares | Sole | 2023-05-09 | |
| 2022-12-31 | $278,419 | 3,069 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $231,298 | 3,043 | Shares | Sole | 2022-11-02 | |
| 2022-06-30 | $234,317 | 2,772 | Shares | Sole | 2022-07-29 | |
| 2022-03-31 | $239,206 | 2,726 | Shares | Sole | 2022-05-04 | |
| 2021-12-31 | $226,284 | 2,587 | Shares | Sole | 2022-02-02 | |
| 2021-09-30 | $211,564 | 2,587 | Shares | Sole | 2021-10-27 | |
| 2021-06-30 | $236,676 | 2,594 | Shares | Sole | 2021-07-27 | |
| 2021-03-31 | $221,820 | 2,595 | Shares | Sole | 2021-05-06 | |
| 2020-12-31 | $245,045 | 2,595 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $225,574 | 2,594 | Shares | Sole | 2020-10-19 | |
| 2020-06-30 | $228,044 | 2,611 | Shares | Sole | 2020-07-22 | |
| 2020-03-31 | $214,122 | 2,597 | Shares | Sole | 2020-05-07 | |
| No filing history on record for this holder in this stock. | ||||||